ACCURAY INC (ARAY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

ACCURAY INC (ARAY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (a) On October 8, 2026, Mika Nishimura, a Class II director of Accuray Incorporated (the “Company”), informed the Company’s

Event · Exec change
Person
Mika Nishimura
Title
Class II director

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Oct 13, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$ARAY
Neutral
high confidence
Mentioned
$ARAY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARAYNeutralLow
01

Why it matters

The filing provides a clear, first‑hand update on board composition, but no immediate operational impact.

02

Market read

A routine governance filing with limited trading relevance; investors may monitor for any subsequent board changes.

03

What to watch

Potential hidden strategic disagreements not disclosed in the filing.

Relevance 6/10Novelty 5/10Timing: same day filing

Background

SEC Form 8‑K filings are required for material corporate events; director changes are standard disclosures.

Company-level read

Ticker impact

$ARAYNeutralHigh confidence
Context

Accuray disclosed that director Mika Nishimura will not stand for re‑election, a new corporate governance filing.

Expected impact

likely neutral as investors assess the board change without operational implications

Evidence & confidence

SEC Form 8‑K filing is the first report of the departure; no financial or strategic change is indicated.

Market effects

Minimal effect on the medical device sector; governance updates are routine.

No regional impact beyond Accuray's shareholder base.

Not globally material.

Counterpoint

If the departing director held key relationships, her exit could signal future board shifts.

Key entities

  • Accuray Inc.

    Medical device manufacturer listed on NASDAQ under ARAY.

  • Mika Nishimura

    Class II director and Compensation Committee chair.

Related articles

$ARAYMed

Accuray Inc (ARAY) (Q1 2027) Earnings Call Highlights: Service Strength and Cost Cuts Offset

Accuray Inc (ARAY) reported Q1 2027 net revenue of $86.5M, down 8% YoY, missing expectations. Service revenue grew 4% to $59.2M, while product revenue fell 26% to $27.3M. Adjusted EBITDA turned positive at $2.5M. The company cited geopolitical factors in China as a key headwind. Operating expenses decreased 25%, and the installed base surpassed 1,100 systems, supporting $230M in recurring annual revenue.

$ARAYMed

Product sales fell 26% at Accuray, while service revenue grew 4%

Accuray reported a 26% decline in product sales but a 4% increase in service revenue to $59.2 million. Service gross margin rose 120 basis points to 35.1%. Operating expenses fell 29% excluding a $62.6 million goodwill impairment charge. The company signed agreements with RaySearch and Samsung NeuroLogica. Total revenue was $103.2 million, with a net income of $13 million. Accuray did not provide formal guidance for fiscal 2027, focusing on execution and commercial performance.

$ARAYHigh

Accuray Reports Fiscal 2027 First Quarter Financial Results

ACCURAY INC (ARAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Accuray Reports Fiscal 2027 First Quarter Financial Results MADISON, Wisconsin, November 4, 2026 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2026 . Key Highlights ● Service revenue grew 4% year-over

Low

[SCHEDULE 13D/A] ACCURAY INC Amended Major Shareholder Report

Accuray Inc. amended a major shareholder report, detailing a $55M issuance of Series A Convertible Preferred Stock to investors, including affiliates of the reporting person. The deal involves $15M in cash and $40M in debt conversion, with warrants issued as incentives. The transaction is subject to closing conditions and stockholder approval. If not approved, a $15M fee is payable. The Series A Preferred Stock is convertible into common stock at $0.50 per share. TCW Asset Management gains board